On Monday, Paris-based drug company HRA Pharma sent a formal request to the Food and Drug Administration (FDA) asking that the regulatory agency approve birth control pills for over-the-counter availability. If approved, the drugs would be widely available without a prescription.
While the application follows the Supreme Court's decision to overturn Roe v. Wade (1973), ending the federal right to abortion, HRA Pharma told the Associated Press that the application is unrelated to current political events.
